Initially identified as a tumor-suppressor gene with apoptosis-inducing activities in prostate cancer, GLIPR1 pleiotropic effects have been reported to be highly expressed and upregulated, and it acts as an oncogene specifically in glioblastomas and gliomas, thus promoting cell proliferation[127,130,131]. Here, GLIPR1 is linked to central nervous system cancer.